Please Wait
Applying Filters...
menu
    • menu
    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Metoprolol Tartrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 39Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Senores Pharma Gets USFDA Nod For Metoprolol, Hydrochlorothiazide
    Senores Pharma Gets USFDA Nod For Metoprolol, Hydrochlorothiazide

    10 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/senores-pharma-gets-final-approval-for-metoprolol-tartrate-and-hydrochlorothiazide-tablets-125011000360_1.html

    BUSINESS STD
    10 Jan 2025
    Share Share
    DoP Rejects Review Applications on Metoprolol Pricing
    DoP Rejects Review Applications on Metoprolol Pricing

    24 Oct 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=173182&sid=1

    PHARMABIZ
    24 Oct 2024
    Share Share
    Enforcement Report - Week of June 5, 2024
    Enforcement Report - Week of June 5, 2024

    05 Jun 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-5-2024-58484.pdf

    FDA
    05 Jun 2024
    Share Share
    Cytokinetics Announces Start of MAPLE-HCM, a Ph3 Trial of Aficamten Metoprolol
    Cytokinetics Announces Start of MAPLE-HCM, a Ph3 Trial of Aficamten Metoprolol

    20 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/20/2690946/35409/en/Cytokinetics-Announces-Start-of-MAPLE-HCM-a-Phase-3-Clinical-Trial-of-Aficamten-Compared-to-Metoprolol-in-Patients-With-Symptomatic-Obstructive-Hypertrophic-Cardiomyopathy.html

    GLOBENEWSWIRE
    20 Jun 2023
    Share Share
    Enforcement Report - Week of February 1, 2023
    Enforcement Report - Week of February 1, 2023

    01 Feb 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416

    FDA
    01 Feb 2023
    Share Share
    Enforcement Report - Week of January 19, 2022
    Enforcement Report - Week of January 19, 2022

    19 Jan 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-19-2022-1642582122.pdf

    FDA
    19 Jan 2022
    Share Share